RUBICON FDA Approval ANDA 216876

ANDA 216876

RUBICON

FDA Drug Application

Application #216876

Application Sponsors

ANDA 216876RUBICON

Marketing Status

Prescription001

Application Products

001CAPSULE;ORAL2MG0LOPERAMIDE HYDROCHLORIDELOPERAMIDE HYDROCHLORIDE

FDA Submissions

UNKNOWN; ORIG1AP2023-01-26STANDARD

Submissions Property Types

ORIG1Null7

TE Codes

001PrescriptionAB

CDER Filings

RUBICON
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 216876
            [companyName] => RUBICON
            [docInserts] => ["",""]
            [products] => [{"drugName":"LOPERAMIDE HYDROCHLORIDE","activeIngredients":"LOPERAMIDE HYDROCHLORIDE","strength":"2MG","dosageForm":"CAPSULE;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"01\/26\/2023","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2023-01-26
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.